Panel Discussion: How Are Regulators & Industry Thinking About Degraders from a Safety Perspective in 2025?

Time: 10:00 am
day: Day One AM

Details:

  • What if anything has changed on the FDA side with regards regulation of degraders?
  • What is the pre-clinical and clinical data telling us thus far for degraders?
  • Where are the opportunities for collaboration between stakeholders to drive these needs forward?

Speakers: